Webinar: New Non-dilutive Funding Resource for BioUtah Members
June 25, 2021
If you weren’t able to join the Government to Growth (G2G) webinar held on June 21, the recording is now available.
The webinar launched BioUtah’s new initiative to bring the vast array of the federal government’s non-dilutive funding opportunities to the doorstep of Utah’s life sciences community. BioUtah has contracted with G2G, Washington DC’s premier consulting firm for non-dilutive funding, to receive a detailed monthly report on the funding landscape. G2G will also be holding monthly webinars to assist BioUtah members in understanding the various funding options that fit our industry and how to navigate the system.
The monthly report is now available to all BioUtah members. To obtain the most recent report, simply request an access code. Follow-up webinars to review current non-dilutive funding opportunities will be held July 19 and August 16, 2021 at 1:00 PM MDT.
The recent webinar reviewed the June funding report.
Recent News
- RefloDx Closes $2 Million Seed Round to Advance Noninvasive Testing for Chronic Throat and Voice Symptoms
- Myriad Genetics Releases New MONSTAR-SCREEN-3 Data Demonstrating the Potential of Ultra-Sensitive MRD Detection in Colorectal and Pancreatic Cancers
- Ultragenyx sells second rare pediatric PRV in a week for $203M
- Co-Diagnostics’ Joint Venture CoMira Diagnostics Invited by Saudi Ministry to Participate in Strategic Manufacturing Forum
- Route 92 Medical Announces $100 Million Corporate Debt Facility
- Myriad Genetics and Labcorp Announce Definitive Agreement for Myriad to Sell Prenatal Health Testing Business to Labcorp
